Eudaimonia Partners’s Verastem VSTM Stock Holding History

Eudaimonia Partners’s Portfolio VSTM Stock Details VSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-83	Closed	-$2K	–	1348
2021 Q1	$2K	Buy	+83	New	+$2.33K	﹤0.01%	1503

Other funds holding VSTM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Eudaimonia Partners's VSTM Position: Q2 2021 in Review

Eudaimonia Partners sold out of Verastem (VSTM) in Q2 2021, closing a stake of 83 shares — an estimated $2K sold.

Eudaimonia Partners first reported a position in VSTM in Q1 2021 and held it in 1 quarter. The position peaked at $2K in Q1 2021. 152 funds tracked by Wall St. Rank hold VSTM as of Q2 2021.

Eudaimonia Partners reported no remaining Verastem position as of Q2 2021 after selling out during the quarter.
Eudaimonia Partners sold 83 Verastem shares in Q2 2021, an estimated $2K.
Eudaimonia Partners first reported a position in Verastem in Q1 2021 and held it in 1 quarter.
Eudaimonia Partners's Verastem position peaked at $2K in Q1 2021.
152 funds tracked by Wall St. Rank held Verastem as of Q2 2021.

Based on Eudaimonia Partners's 13F filing for Q2 2021, filed 13 Aug 2021.